Information Provided By:
Fly News Breaks for January 22, 2016
IMPV
Jan 22, 2016 | 07:37 EDT
Stephens analyst Jonathan Ruykhaver said his talks with Imperva partners keep him convinced that the company is well positioned for strong organic growth and he expects its Q4 results to beat expectations. The analyst thinks the selloff in Imperva shares has been overdone and keeps an Overweight rating on the stock, but lowered his price target to $70 from $78 to reflect depressed valuations across the space.
News For IMPV From the Last 2 Days
There are no results for your query IMPV